Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Quin

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
European Journal of Immunology|February 13, 2001
Low CD4(+) T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathwaysS J Quin, E M Seixas, C A Cross, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 1998
Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy womenE R Richards, P L Devine, R J Quin, et al.
Disease Markers|December 30, 1998
Monoclonal antibody recognizing a core epitope on mucinP L Devine, R J Quin, P W Shield, et al.
The International Journal of Biological Markers|October 1, 1995
Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate diseaseP L Devine, M D Walsh, M A McGuckin, et al.
The American Journal of Tropical Medicine and Hygiene|February 1, 1995
Tropical spastic paraparesis on the Caribbean coast of ColombiaF Dangond, J S Daza, A Rosania, et al.
Breast Cancer Research and Treatment|June 1, 1995
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancerP L Devine, M A Duroux, R J Quin, et al.
Disease Markers|July 31, 1999
Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicityP L Devine, W J Siebert, S L Morton, et al.
Journal of Leukocyte Biology|October 16, 2002
MUC1 epithelial mucin (CD227) is expressed by activated dendritic cellsM Wykes, K P A MacDonald, M Tran, et al.
The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.
Ophthalmology|January 20, 2016
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
European Journal of Immunology|February 13, 2001
Low CD4(+) T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathwaysS J Quin, E M Seixas, C A Cross, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 1998
Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy womenE R Richards, P L Devine, R J Quin, et al.
Disease Markers|December 30, 1998
Monoclonal antibody recognizing a core epitope on mucinP L Devine, R J Quin, P W Shield, et al.
The International Journal of Biological Markers|October 1, 1995
Prostate-specific antigen (PSA) and cancer-associated serum antigen (CASA) in distinguishing benign and malignant prostate diseaseP L Devine, M D Walsh, M A McGuckin, et al.
The American Journal of Tropical Medicine and Hygiene|February 1, 1995
Tropical spastic paraparesis on the Caribbean coast of ColombiaF Dangond, J S Daza, A Rosania, et al.
Breast Cancer Research and Treatment|June 1, 1995
CA15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancerP L Devine, M A Duroux, R J Quin, et al.
Disease Markers|July 31, 1999
Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicityP L Devine, W J Siebert, S L Morton, et al.
Journal of Leukocyte Biology|October 16, 2002
MUC1 epithelial mucin (CD227) is expressed by activated dendritic cellsM Wykes, K P A MacDonald, M Tran, et al.
The British Journal of Ophthalmology|November 6, 2015
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialHemal Mehta, Samantha Fraser-Bell, Aaron Yeung, et al.
Ophthalmology|January 20, 2016
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study)Samantha Fraser-Bell, Lyndell L Lim, Anna Campain, et al.
Pageof 5